HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future.

AuthorsJack L Arbiser
JournalJAMA dermatology (JAMA Dermatol) Vol. 151 Issue 7 Pg. 703-4 (Jul 2015) ISSN: 2168-6084 [Electronic] United States
PMID25692853 (Publication Type: Editorial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Antibiotics, Antineoplastic
  • Sirolimus
Topics
  • Antibiotics, Antineoplastic (therapeutic use)
  • Female
  • Humans
  • Hypopigmentation (drug therapy)
  • Male
  • Melanosomes (ultrastructure)
  • Sirolimus (therapeutic use)
  • Skin Neoplasms (drug therapy)
  • Tuberous Sclerosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: